Get startedLog in
    Picture of Biocon logo

    BIOCON — Biocon Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Biocon, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:——
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line8,7098,5597,7166,43012,978
    Depreciation
    Non-Cash Items3,6922,0636,4238,26010,148
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-5,092-6,514-10,177-7,296-9,275
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities12,83111,25912,10418,52529,539
    Capital Expenditures-18,365-17,463-19,248-17,263-19,316
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items2,776-18,7842,257-125,5559,271
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-15,589-36,247-16,991-142,818-10,045
    Financing Cash Flow Items-937-1,160-1,096-4,856-8,474
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities3,87625,6402,421130,487-23,327
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash1,654723-2,4336,411-3,804